PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

GSK to support manufacture of Novavax’ COVID-19 vaccine

GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million doses of Novavax' COVID-...
Continue Reading →
News

FDA nod for Kiniksa’s Arcalyst in recurrent pericarditis

The US Food and Drug Administration (FDA) has approved Kiniksa Pharmaceuticals’ interleukin-1 alpha (IL-1?) and interleukin-1 beta (IL-1?) inhibitor Arcalyst (rilona...
Continue Reading →
News

Researchers identify molecular ‘cookie cutter’ technique for COVID-19 drug discovery

Researchers from the University of Birmingham are aiming to isolate and extract the COVID-19 encounter complex for the identification of drug-target sites for the di...
Continue Reading →
News

FDA refuses Novo Nordisk’s once-weekly semaglutide

Novo Nordisk has received a refusal to file letter from the US Food and Drug Administration (FDA) for a label expansion application for semaglutide.   The appli...
Continue Reading →
News

NICE approves ovarian cancer drug combination via Cancer Drugs Fund

A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be a...
Continue Reading →
News

NIAID statement on AstraZeneca vaccine and AstraZeneca update

Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initi...
Continue Reading →
News

Roche discontinues tominerson study in manifest Huntington’s disease

Roche has announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington’s disease (HD). The decision was ba...
Continue Reading →
News

Novavax’s COVID-19 vaccine ‘highly’ effective against UK variant

Novavax has announced that its COVID-19 vaccine NVX-CoV2373 has a final efficacy of 96.3% against mild, moderate and severe disease caused by the original COVID-19 s...
Continue Reading →
News

First participants dosed in Phase 1 study evaluating mRNA-1283, Moderna’s next generation COVID-19 vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants have bee...
Continue Reading →
News

Lilly’s mirikizumab hits primary endpoint in ulcerative colitis study

Eli Lilly’s anti-IL-23p19 monoclonal antibody (mAb) mirikizumab has met the primary endpoint and all key secondary endpoints in a Phase III ulcerative colitis (UC) s...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026